“Mipomersen sodium did not exhibit genotoxic potential in a battery of studies, including the in vitro Bacterial Reverse Mutation (Ames) assay, an in vitro cytogenetics assay using a mouse lymphoma cell line, and an in vivo micronucleus assay in mice.”
✓ VerifiedFDA pharmacology/toxicology review, p. 13Source ↗
“The Committee concluded that hepatocellular adenomas and combined hepatocellular adenomas or carcinomas were drug-related in female mice administered 60 mg/kg/week mipomersen.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Reproductive & developmental
Mouse fertility/EFD and rabbit EFD (not teratogenic); rat PPND pup effects; juvenile rat study
“Mipomersen was not teratogenic in mice or rabbits at doses providing modest margins of exposure (2 to 5 times) compared to humans.”
✓ VerifiedFDA pharmacology/toxicology review, p. 2Source ↗
Safety pharmacology
hERG, mouse respiratory and Irwin studies; CV telemetry within 13-week monkey tox study
“Heart rate, mean arterial pressure and EKG were evaluated by telemetry in monkeys after single and repeat doses of 3 to 35 mg/kg/wk for 13 weeks (Study AS02).”
✓ VerifiedFDA pharmacology/toxicology review, p. 39Source ↗